G, M., M, M., C, C., MR, B., V, S., & G, B. (2023). Letter: Post-COVID-19 functional dyspepsia and irritable bowel syndrome-Authors' reply. Alimentary pharmacology & therapeutics, 58(1), 128. https://doi.org/10.1111/apt.17554
Chicago Style (17th ed.) CitationG, Marasco, Maida M, Cremon C, Barbaro MR, Stanghellini V, and Barbara G. "Letter: Post-COVID-19 Functional Dyspepsia and Irritable Bowel Syndrome-Authors' Reply." Alimentary Pharmacology & Therapeutics 58, no. 1 (2023): 128. https://doi.org/10.1111/apt.17554.
MLA (9th ed.) CitationG, Marasco, et al. "Letter: Post-COVID-19 Functional Dyspepsia and Irritable Bowel Syndrome-Authors' Reply." Alimentary Pharmacology & Therapeutics, vol. 58, no. 1, 2023, p. 128, https://doi.org/10.1111/apt.17554.